Literature DB >> 3790257

Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase.

L Weiss, G E Hoffmann, R Schreiber, H Andres, E Fuchs, E Körber, H J Kolb.   

Abstract

Fatty-acid synthase has been purified to homogeneity from human liver by a 3-step procedure including protamine sulfate/ammonium sulfate fractionation, affinity chromatography on 2',5'-ADP-Sepharose 4B and gel filtration on Sephacryl S-300. Both the human and rat fatty-acid synthase had similar characteristics regarding molecular mass, subunit structure, amino-acid composition, and substrate affinities. In order to measure the fatty-acid synthase activities in small tissue samples it was necessary to improve the sensitivity of an isotopic assay using [14C]malonyl-CoA as tracer. Special attention was paid to the dual role of free CoASH as an activator and inhibitor of the enzyme. Considerable differences existed between the specific activities of the fatty-acid synthase complex measured in human and rat lipogenic organs. Only negligible values of about 1 mU/mg protein were found in human liver and adipose tissue, while the corresponding activities were 10- to 50-fold higher in young lean rats. Less pronounced but still remarkable differences were determined for the activity of the acetyltransferase which catalyses the initial primer reaction of the fatty-acid synthase complex. In some selected cases under long-term fat-free diet (alcoholism, parenteral nutrition) elevated values of fatty-acid synthase activities were detected in human tissues. Under usual diet, with a relatively high fat content of up to 40 percent, and even after a carbohydrate-rich diet for three days, fatty-acid synthase activity remained low. It is concluded that under the dietary conditions, common for the industrialized world, de novo lipogenesis in man is negligible.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3790257     DOI: 10.1515/bchm3.1986.367.2.905

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  49 in total

1.  Fatty acid synthase expression and esophageal cancer.

Authors:  Yongli Zhou; Chunyan Niu; Yandong Li; Baohua Gao; Jianyun Zheng; Xiaoli Guo; Weiguo Ma
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

2.  Substrate recognition by the human fatty-acid synthase.

Authors:  Loretha Carlisle-Moore; Chris R Gordon; Carl A Machutta; W Todd Miller; Peter J Tonge
Journal:  J Biol Chem       Date:  2005-10-07       Impact factor: 5.157

3.  Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.

Authors:  Lei Li; Li Che; Kevin M Tharp; Hyo-Min Park; Maria G Pilo; Dan Cao; Antonio Cigliano; Gavinella Latte; Zhong Xu; Silvia Ribback; Frank Dombrowski; Matthias Evert; Gregory J Gores; Andreas Stahl; Diego F Calvisi; Xin Chen
Journal:  Hepatology       Date:  2016-03-25       Impact factor: 17.425

4.  FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.

Authors:  Olga V Danilova; Larry J Dumont; Norman B Levy; Frederick Lansigan; William B Kinlaw; Alexey V Danilov; Prabhjot Kaur
Journal:  J Hematop       Date:  2013-03       Impact factor: 0.196

5.  Lipoprotein lipase links dietary fat to solid tumor cell proliferation.

Authors:  Nancy B Kuemmerle; Evelien Rysman; Portia S Lombardo; Alison J Flanagan; Brea C Lipe; Wendy A Wells; Jason R Pettus; Heather M Froehlich; Vincent A Memoli; Peter M Morganelli; Johannes V Swinnen; Luika A Timmerman; Leila Chaychi; Catherine J Fricano; Burton L Eisenberg; William B Coleman; William B Kinlaw
Journal:  Mol Cancer Ther       Date:  2011-01-31       Impact factor: 6.261

Review 6.  The role of sex steroid receptors on lipogenesis in breast and prostate carcinogenesis: a viewpoint.

Authors:  Henri Rochefort; Dany Chalbos
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

7.  Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.

Authors:  Ligong Chang; Peng Wu; Ravichandran Senthilkumar; Xiaoqiang Tian; Hui Liu; Xia Shen; Zijian Tao; Peilin Huang
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-25       Impact factor: 4.553

8.  Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention.

Authors:  Kathleen E Kearney; Thomas G Pretlow; Theresa P Pretlow
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

9.  A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site.

Authors:  Mary Ann Hardwicke; Alan R Rendina; Shawn P Williams; Michael L Moore; Liping Wang; Julie A Krueger; Ramona N Plant; Rachel D Totoritis; Guofeng Zhang; Jacques Briand; William A Burkhart; Kristin K Brown; Cynthia A Parrish
Journal:  Nat Chem Biol       Date:  2014-08-03       Impact factor: 15.040

10.  Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma.

Authors:  Snezana Pejić; Ana Todorović; Vesna Stojiljković; Jelena Kasapović; Snezana B Pajović
Journal:  Reprod Biol Endocrinol       Date:  2009-12-23       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.